Email ID
Password
Scrip   
India looms large in biosimilars segment
25 March 2009
Ian Schofield

News that the Indian government plans to make almost $70 million in funding available for the development of biosimilar medicines is good news for domestic generics firms.

But it should sound a warning bell among innovative biotech companies, particularly in the US, where legislation allowing...



Please Login to read the full article.
JOB OF THE WEEK Promote your vacancy here
© 2010 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36